OYEN, Willem Jozef Gerard
OYEN, Willem Jozef Gerard
Dipartimento Scienze Biomediche
(18)FDG-PET for staging (non)seminomatous germ cell tumours [(N)SGCT] and for evaluation of postchemotherapy residual masses.
2001-01-01 Spermon, Jr; De geus-Oei, Lf; Debruyne, Fm; Kiemeney, La; Corstens, Fh; Witjes, Ja; Oyen, W
18-F fluorodeoxygenase (FDG) positron emission tomography (PET) scanning prior to radical lung radiotherapy. A retrospective audit of practice
2017-01-01 Bainbridge, H; Locke, I; Ahmed, M; Oyen, W; Mcdonald, F
18F-FDG PET-CT in rheumatoid arthritis patients tapering TNFi: reliability, validity and predictive value
2022-01-01 Bouman, Chantal A M; van Herwaarden, Noortje; Blanken, Annelies B; Van der Laken, Conny J; Gotthardt, Martin; Oyen, W.; den Broeder, Alfons A; van der Maas, Aatke; van den Ende, Cornelia H
18F-FDG PET/CT in Detecting Metastatic Infection in Children
2016-01-01 Kouijzer, Ije; Blokhuis, Gj; Draaisma, Jmt; Oyen, W; de Geus-Oei, Lf; Bleeker-Rovers, Cp
18F-FDG-PET reduces the number of direct laryngoscopies in patients with suspected recurrent laryngeal carcinoma after radiotherapy
2014-01-01 de Bree, R; Van der Putten, L; van Tinteren, H; Wedman, J; Oyen, W; Hobbelink, Mggmgg; Olmos, Rv; Boers, M; Hoekstra, O; Leemans, Cr
18F-FLT-PET for the evaluation of MEK inhibitor AZD6244
2008-01-01 Desar, I; Gilles, R; Timmer-Bonte, A; Cantarini, Mv; van Herpen, Cml; Oyen, W; van der Graaf, Wta
2-(F-18)-fluoro-2-deoxy-D-glucose positron emission tomography detects clinical relevant adenomas of the colon: A prospective study
2005-01-01 van Kouwen, Mca; Nagengast, Fm; Jansen, Jbmj; Oyen, W; Drenth, Jph
3 '-Deoxy-3 '-F-18-Fluorothymidine PET-Derived Proliferative Volume Predicts Overall Survival in High-Grade Glioma Patients
2012-01-01 Idema, Ajs; Hoffmann, Al; Boogaarts, Hd; Troost, Egc; Wesseling, P; Heerschap, A; van der Graaf, Wta; Grotenhuis, Ja; Oyen, W
7TH ANNUAL-MEETING OF THE INTERNATIONAL RESEARCH GROUP IN IMMUNOSCINTIGRAPHY AND IMMUNOTHERAPY
1992-01-01 Oyen, W
99mTc-interleukin-8 for imaging acute osteomyelitis
2001-01-01 Gratz, S; Rennen, H; Boerman, O; Oyen, W; Corstens, F
[18F]FDG Uptake and Expression of Immunohistochemical Markers Related to Glycolysis, Hypoxia, and Proliferation in Indeterminate Thyroid Nodules
2023-01-01 de Koster, Elizabeth J.; van Engen-van Grunsven, Adriana C. H.; Bussink, Johan; Frielink, Cathelijne; de Geus-Oei, Lioe-Fee; Kusters, Benno; Peters, Hans; Oyen, W.; Vriens, Dennis; Null, Null; Netea-Maier, Romana T.; Smit, Jan W. A.; de Wilt, Johannes H. W.; Booij, Jan; Fliers, Eric; Klooker, Tamira K.; van Dam, Eveline W. C. M.; Dreijerink, Koen M. A.; Raijmakers, Pieter G. H. M.; Kam, Boen L. R.; Peeters, Robin P.; Verzijlbergen, John F.; van Aken, Maarten O.; Jager, Piet L.; Mijnhout, G. Sophie; van den Hout, Wilbert B.; Arias, Alberto M. Pereira; Morreau, Johannes; Snel, Marieke; Dijkhorst-Oei, Lioe-Ting; de Klerk, John M. H.; Havekes, Bas; Mitea, D. Cristina; Vöö, Stefan; Brouwer, Catharine B.; van Dam, Pieter S.; Sivro, Ferida; te Beek, Erik T.; Jebbink, Max C. W.; Bleumink, Gysele S.; Schelfhout, Vanessa J. R.; Keijsers, Ruth G. M.; Wakelkamp, Iris M. M. J.; Brouwers, Adrienne H.; Links, Thera P.; de Keizer, Bart; van Leeuwaarde, Rachel S.; Bonenkamp, Johannes J.; Donders, A. Rogier T.; Fütterer, Jurgen J.
[18F]FDG-PET/CT to prevent futile surgery in indeterminate thyroid nodules: a blinded, randomised controlled multicentre trial
2022-01-01 de Koster, Elizabeth J.; de Geus-Oei, Lioe-Fee; Brouwers, Adrienne H.; van Dam, Eveline W. C. M.; Dijkhorst-Oei, Lioe-Ting; van Engen-van Grunsven, Adriana C. H.; van den Hout, Wilbert B.; Klooker, Tamira K.; Netea-Maier, Romana T.; Snel, Marieke; Oyen, W.; Vriens, Dennis; Null, Null
[89Zr]-immuno-PET prediction of response to rituximab treatment in patients with therapy refractory interstitial pneumonitis: a phase 2 trial
2023-01-01 Adams, H.; van de Garde, E. M. W.; Vugts, D. J.; Grutters, J. C.; Oyen, W.; Keijsers, R. G.
[89Zr]Zr-DFO-girentuximab and [18F]FDG PET/CT to Predict Watchful Waiting Duration in Patients with Metastatic Clear-cell Renal Cell Carcinoma
2023-01-01 Verhoeff, Sarah R; Oosting, Sjoukje F; Elias, Sjoerd G; van Es, Suzanne C; Gerritse, Sophie L; Angus, Lindsay; Heskamp, Sandra; Desar, Ingrid M E; Menke-van der Houven van Oordt, C Willemien; van der Veldt, Astrid A M; Arens, Anne I J; Brouwers, Adrienne H; Eisses, Bertha; Mulders, Peter F A; Hoekstra, Otto S; Zwezerijnen, Gerben J C; van der Graaf, Winette T A; Aarntzen, Erik H J G; Oyen, W.; van Herpen, Carla M L
[F-18]-Fluorination of a Leukotriene B4 Receptor Antagonist via Hydrazone Formation and its Application in Infection Imaging
2005-01-01 Rennen, Hjjm; Laverman, P; van Eerd, Jem; Oyen, W; Corstens, Fhm; Boerman, Oc
[F-18]FDG accumulation in an experimental model of multistage progression of cholangiocarcinoma
2007-01-01 Laverman, P; Blokx, Wam; Morsche, Rhmt; Frielink, C; Boerman, Oc; Oyen, W; Drenth, Jph
[F-18]fluoro-2-deoxy-d-glucose positron emission tomography detects gastric carcinoma in an early stage in an asymptomatic e-cadherin mutation carrier
2004-01-01 van Kouwen, Mca; Drenth, Jph; Oyen, W; de Bruin, Jhfm; Ligtenberg, Mj; Bonenkamp, Jj; van Krieken, Jhjm; Nagengast, Fm
[Zr-89]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer
2020-01-01 van Helden, Ej; Elias, Sg; Gerritse, Sl; van Es, Sc; Boon, E; Huisman, Mc; van Grieken, Nct; Dekker, H; van Dongen, Gams; Vugts, Dj; Boellaard, R; van Herpen, Cml; de Vries, Ege; Oyen, W; Brouwers, Ah; Verheul, Hmw; Hoekstra, Os; van Oordt, Cwm
A 3-step pretargeting strategy to image infection
2001-01-01 Boerman, Oc; van Eerd, J; Oyen, W; Corstens, Fhm
A bivalent leukotriene B-4 antagonist for scintigraphic Imaging of infectious foci
2003-01-01 van Eerd, Jem; Oyen, W; Harris, Td; Rennen, Hjjm; Edwards, Ds; Liu, S; Ellars, Ce; Corstens, Fhm; Boerman, Oc
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| (18)FDG-PET for staging (non)seminomatous germ cell tumours [(N)SGCT] and for evaluation of postchemotherapy residual masses. | 1-gen-2001 | Spermon, Jr; De geus-Oei, Lf; Debruyne, Fm; Kiemeney, La; Corstens, Fh; Witjes, Ja; Oyen, W | |
| 18-F fluorodeoxygenase (FDG) positron emission tomography (PET) scanning prior to radical lung radiotherapy. A retrospective audit of practice | 1-gen-2017 | Bainbridge, H; Locke, I; Ahmed, M; Oyen, W; Mcdonald, F | |
| 18F-FDG PET-CT in rheumatoid arthritis patients tapering TNFi: reliability, validity and predictive value | 1-gen-2022 | Bouman, Chantal A M; van Herwaarden, Noortje; Blanken, Annelies B; Van der Laken, Conny J; Gotthardt, Martin; Oyen, W.; den Broeder, Alfons A; van der Maas, Aatke; van den Ende, Cornelia H | |
| 18F-FDG PET/CT in Detecting Metastatic Infection in Children | 1-gen-2016 | Kouijzer, Ije; Blokhuis, Gj; Draaisma, Jmt; Oyen, W; de Geus-Oei, Lf; Bleeker-Rovers, Cp | |
| 18F-FDG-PET reduces the number of direct laryngoscopies in patients with suspected recurrent laryngeal carcinoma after radiotherapy | 1-gen-2014 | de Bree, R; Van der Putten, L; van Tinteren, H; Wedman, J; Oyen, W; Hobbelink, Mggmgg; Olmos, Rv; Boers, M; Hoekstra, O; Leemans, Cr | |
| 18F-FLT-PET for the evaluation of MEK inhibitor AZD6244 | 1-gen-2008 | Desar, I; Gilles, R; Timmer-Bonte, A; Cantarini, Mv; van Herpen, Cml; Oyen, W; van der Graaf, Wta | |
| 2-(F-18)-fluoro-2-deoxy-D-glucose positron emission tomography detects clinical relevant adenomas of the colon: A prospective study | 1-gen-2005 | van Kouwen, Mca; Nagengast, Fm; Jansen, Jbmj; Oyen, W; Drenth, Jph | |
| 3 '-Deoxy-3 '-F-18-Fluorothymidine PET-Derived Proliferative Volume Predicts Overall Survival in High-Grade Glioma Patients | 1-gen-2012 | Idema, Ajs; Hoffmann, Al; Boogaarts, Hd; Troost, Egc; Wesseling, P; Heerschap, A; van der Graaf, Wta; Grotenhuis, Ja; Oyen, W | |
| 7TH ANNUAL-MEETING OF THE INTERNATIONAL RESEARCH GROUP IN IMMUNOSCINTIGRAPHY AND IMMUNOTHERAPY | 1-gen-1992 | Oyen, W | |
| 99mTc-interleukin-8 for imaging acute osteomyelitis | 1-gen-2001 | Gratz, S; Rennen, H; Boerman, O; Oyen, W; Corstens, F | |
| [18F]FDG Uptake and Expression of Immunohistochemical Markers Related to Glycolysis, Hypoxia, and Proliferation in Indeterminate Thyroid Nodules | 1-gen-2023 | de Koster, Elizabeth J.; van Engen-van Grunsven, Adriana C. H.; Bussink, Johan; Frielink, Cathelijne; de Geus-Oei, Lioe-Fee; Kusters, Benno; Peters, Hans; Oyen, W.; Vriens, Dennis; Null, Null; Netea-Maier, Romana T.; Smit, Jan W. A.; de Wilt, Johannes H. W.; Booij, Jan; Fliers, Eric; Klooker, Tamira K.; van Dam, Eveline W. C. M.; Dreijerink, Koen M. A.; Raijmakers, Pieter G. H. M.; Kam, Boen L. R.; Peeters, Robin P.; Verzijlbergen, John F.; van Aken, Maarten O.; Jager, Piet L.; Mijnhout, G. Sophie; van den Hout, Wilbert B.; Arias, Alberto M. Pereira; Morreau, Johannes; Snel, Marieke; Dijkhorst-Oei, Lioe-Ting; de Klerk, John M. H.; Havekes, Bas; Mitea, D. Cristina; Vöö, Stefan; Brouwer, Catharine B.; van Dam, Pieter S.; Sivro, Ferida; te Beek, Erik T.; Jebbink, Max C. W.; Bleumink, Gysele S.; Schelfhout, Vanessa J. R.; Keijsers, Ruth G. M.; Wakelkamp, Iris M. M. J.; Brouwers, Adrienne H.; Links, Thera P.; de Keizer, Bart; van Leeuwaarde, Rachel S.; Bonenkamp, Johannes J.; Donders, A. Rogier T.; Fütterer, Jurgen J. | |
| [18F]FDG-PET/CT to prevent futile surgery in indeterminate thyroid nodules: a blinded, randomised controlled multicentre trial | 1-gen-2022 | de Koster, Elizabeth J.; de Geus-Oei, Lioe-Fee; Brouwers, Adrienne H.; van Dam, Eveline W. C. M.; Dijkhorst-Oei, Lioe-Ting; van Engen-van Grunsven, Adriana C. H.; van den Hout, Wilbert B.; Klooker, Tamira K.; Netea-Maier, Romana T.; Snel, Marieke; Oyen, W.; Vriens, Dennis; Null, Null | |
| [89Zr]-immuno-PET prediction of response to rituximab treatment in patients with therapy refractory interstitial pneumonitis: a phase 2 trial | 1-gen-2023 | Adams, H.; van de Garde, E. M. W.; Vugts, D. J.; Grutters, J. C.; Oyen, W.; Keijsers, R. G. | |
| [89Zr]Zr-DFO-girentuximab and [18F]FDG PET/CT to Predict Watchful Waiting Duration in Patients with Metastatic Clear-cell Renal Cell Carcinoma | 1-gen-2023 | Verhoeff, Sarah R; Oosting, Sjoukje F; Elias, Sjoerd G; van Es, Suzanne C; Gerritse, Sophie L; Angus, Lindsay; Heskamp, Sandra; Desar, Ingrid M E; Menke-van der Houven van Oordt, C Willemien; van der Veldt, Astrid A M; Arens, Anne I J; Brouwers, Adrienne H; Eisses, Bertha; Mulders, Peter F A; Hoekstra, Otto S; Zwezerijnen, Gerben J C; van der Graaf, Winette T A; Aarntzen, Erik H J G; Oyen, W.; van Herpen, Carla M L | |
| [F-18]-Fluorination of a Leukotriene B4 Receptor Antagonist via Hydrazone Formation and its Application in Infection Imaging | 1-gen-2005 | Rennen, Hjjm; Laverman, P; van Eerd, Jem; Oyen, W; Corstens, Fhm; Boerman, Oc | |
| [F-18]FDG accumulation in an experimental model of multistage progression of cholangiocarcinoma | 1-gen-2007 | Laverman, P; Blokx, Wam; Morsche, Rhmt; Frielink, C; Boerman, Oc; Oyen, W; Drenth, Jph | |
| [F-18]fluoro-2-deoxy-d-glucose positron emission tomography detects gastric carcinoma in an early stage in an asymptomatic e-cadherin mutation carrier | 1-gen-2004 | van Kouwen, Mca; Drenth, Jph; Oyen, W; de Bruin, Jhfm; Ligtenberg, Mj; Bonenkamp, Jj; van Krieken, Jhjm; Nagengast, Fm | |
| [Zr-89]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer | 1-gen-2020 | van Helden, Ej; Elias, Sg; Gerritse, Sl; van Es, Sc; Boon, E; Huisman, Mc; van Grieken, Nct; Dekker, H; van Dongen, Gams; Vugts, Dj; Boellaard, R; van Herpen, Cml; de Vries, Ege; Oyen, W; Brouwers, Ah; Verheul, Hmw; Hoekstra, Os; van Oordt, Cwm | |
| A 3-step pretargeting strategy to image infection | 1-gen-2001 | Boerman, Oc; van Eerd, J; Oyen, W; Corstens, Fhm | |
| A bivalent leukotriene B-4 antagonist for scintigraphic Imaging of infectious foci | 1-gen-2003 | van Eerd, Jem; Oyen, W; Harris, Td; Rennen, Hjjm; Edwards, Ds; Liu, S; Ellars, Ce; Corstens, Fhm; Boerman, Oc |